Abstract
Pluripotent human stem cells, including embryonic stem (ES) cells and induced pluripotent stem (iPS) cells, hold tremendous promise as a source of progenitor cells and terminally differentiated cells in tissue engineering and regenerative medicine applications. Pluripotent stem cells are capable of unlimited self-renewal and have the ability to differentiate to clinically relevant cell types in each of the three germ lineages. ES cells were first derived from the inner cell mass of the blastocyst, while iPS cells can be generated from differentiated cells by stimulating expression of transcription factors that regulate pluripotency. This chapter discusses advances in deriving, characterizing, and culturing pluripotent human stem cell lines, with a focus on using these lines as a cell source for tissue engineering applications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
